These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12434455)

  • 1. Clinical outcomes of nocturnal dialysis.
    Sherer M
    Nephrol Nurs J; 2002 Oct; 29(5):487-8. PubMed ID: 12434455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodialysis adequacy and quality of life: how do they relate?
    Hamilton G; Locking-Cusolito H
    CANNT J; 2003; 13(4):24-9. PubMed ID: 14753099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does frequent nocturnal hemodialysis result in better outcomes than conventional thrice-weekly hemodialysis?
    Pierratos A
    Nat Clin Pract Nephrol; 2008 Mar; 4(3):132-3. PubMed ID: 18059386
    [No Abstract]   [Full Text] [Related]  

  • 4. Pseudohyperphosphatemia in a hyperphosphatemic hemodialysis patient.
    Suchin EJ; Cizman B; Connolly BR; DiBattista WJ; Agus ZS
    Am J Kidney Dis; 2002 Nov; 40(5):E18. PubMed ID: 12407666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short daily and nocturnal hemodialysis: new therapies for a new century?
    Rocco MV
    Saudi J Kidney Dis Transpl; 2009 Jan; 20(1):1-11. PubMed ID: 19112213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When to start dialysis?
    Douma CE; Smit W
    Nephrol Dial Transplant; 2006 Jul; 21 Suppl 2():ii20-4. PubMed ID: 16825255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contribution of hypertension to dialysis patient outcomes. A point of view.
    Mailloux LU; Bellucci AG; Napolitano B; Mossey RT
    ASAIO J; 1994; 40(2):130-7. PubMed ID: 8003749
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of increasing blood flow rate on dialysis adequacy in hemodialysis patients.
    Borzou SR; Gholyaf M; Zandiha M; Amini R; Goodarzi MT; Torkaman B
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):639-42. PubMed ID: 19587507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minutes to recovery after a hemodialysis session: a simple health-related quality of life question that is reliable, valid, and sensitive to change.
    Lindsay RM; Heidenheim PA; Nesrallah G; Garg AX; Suri R;
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):952-9. PubMed ID: 17699312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension is harmful to dialysis patients and should be controlled.
    Foley RN; Agarwal R
    Semin Dial; 2007; 20(6):518-22. PubMed ID: 17991197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nocturnal hemodialysis on melatonin rhythm and sleep-wake behavior: an uncontrolled trial.
    Koch BC; Hagen EC; Nagtegaal JE; Boringa JB; Kerkhof GA; Ter Wee PM
    Am J Kidney Dis; 2009 Apr; 53(4):658-64. PubMed ID: 18950916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A patient's perspective on nocturnal dialysis.
    Kelley K
    Nephrol News Issues; 2001 Apr; 15(5):63. PubMed ID: 12108967
    [No Abstract]   [Full Text] [Related]  

  • 13. Phosphorus balance with daily dialysis.
    Kooienga L
    Semin Dial; 2007; 20(4):342-5. PubMed ID: 17635826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment time, chronic inflammation, and hemodynamic stability: the overlooked parameters in hemodialysis quantification.
    Zsom L; Zsom M; Fulop T; Flessner MF
    Semin Dial; 2008; 21(5):395-400. PubMed ID: 18945325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Control of arterial hypertension by means of a regimen of hemodialysis on alternate days (HDAA or EODD: "Every Other Day Dialysis") versus 2 conventional regiments of 4 and 5 hours per session 3 times a week with 72 hours without sessions during the weekends].
    Lozano A; Benavides B; Quirós P; Jiménez-Moreno J; Figueroa E; Fernández-Marchena D; García-Pérez MA; Fernández-Ruiz E
    Nefrologia; 2006; 26(6):695-702. PubMed ID: 17227247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A thrice weekly in-center nocturnal hemodialysis program.
    Troidle L; Hotchkiss M; Finkelstein F
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):244-8. PubMed ID: 17603977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE inhibitor-based, directly observed therapy for hypertension in hemodialysis patients.
    Zheng S; Nath V; Coyne DW
    Am J Nephrol; 2007; 27(5):522-9. PubMed ID: 17700014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Single-needle dialysis. Experiences at the Kidney Transplant Unit of the Clinical Hospital of the University of São Paulo Medical School].
    Massola VC; Sabbaga E
    Rev Hosp Clin Fac Med Sao Paulo; 1978 Dec; 33(6):268-71. PubMed ID: 746289
    [No Abstract]   [Full Text] [Related]  

  • 19. High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients.
    Voormolen N; Noordzij M; Grootendorst DC; Beetz I; Sijpkens YW; van Manen JG; Boeschoten EW; Huisman RM; Krediet RT; Dekker FW;
    Nephrol Dial Transplant; 2007 Oct; 22(10):2909-16. PubMed ID: 17517792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporary dialysis treatments for heart failure in chronic kidney disease.
    Iorio L; Violi F; Simonelli R; Nacca RG; Caliendo A; De Santo LS
    Semin Nephrol; 2005 Nov; 25(6):408-12. PubMed ID: 16298264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.